TPM2 and cancer: Given the roles of Tpm2 and fascin in actin cytoskeleton dynamics, downregulation of TPM2 coupled with upregulation of FSCN1 may collectively contribute to cytoskeletal remodeling, enhancing cancer cell motility, invasiveness, and metastatic potential.